HK1006459A1 - Furan derivatives - Google Patents

Furan derivatives

Info

Publication number
HK1006459A1
HK1006459A1 HK98105755A HK98105755A HK1006459A1 HK 1006459 A1 HK1006459 A1 HK 1006459A1 HK 98105755 A HK98105755 A HK 98105755A HK 98105755 A HK98105755 A HK 98105755A HK 1006459 A1 HK1006459 A1 HK 1006459A1
Authority
HK
Hong Kong
Prior art keywords
furan derivatives
gastrointestinal
enterokinetic
expected
activity
Prior art date
Application number
HK98105755A
Other languages
English (en)
Inventor
Setsuya Sasho
Shunji Ichikawa
Hiromasa Kato
Hiroyuki Obase
Katsuichi Shuto
Yoshimasa Oiji
Original Assignee
Kyowa Hakko Kogyo Kk
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kyowa Hakko Kogyo Kk filed Critical Kyowa Hakko Kogyo Kk
Publication of HK1006459A1 publication Critical patent/HK1006459A1/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D307/52—Radicals substituted by nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Nutrition Science (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Furan Compounds (AREA)
HK98105755A 1989-08-17 1998-06-19 Furan derivatives HK1006459A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP21192089 1989-08-17

Publications (1)

Publication Number Publication Date
HK1006459A1 true HK1006459A1 (en) 1999-02-26

Family

ID=16613857

Family Applications (1)

Application Number Title Priority Date Filing Date
HK98105755A HK1006459A1 (en) 1989-08-17 1998-06-19 Furan derivatives

Country Status (10)

Country Link
US (1) US5075301A (ja)
EP (1) EP0413343B1 (ja)
JP (1) JPH0730064B2 (ja)
AT (1) ATE125805T1 (ja)
CA (1) CA2023311C (ja)
DE (1) DE69021294T2 (ja)
DK (1) DK0413343T3 (ja)
ES (1) ES2075098T3 (ja)
GR (1) GR3017870T3 (ja)
HK (1) HK1006459A1 (ja)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9009437D0 (en) * 1990-04-26 1990-06-20 Glaxo Group Ltd Chemical compounds
US5338871A (en) * 1991-12-20 1994-08-16 Torcan Chemical Ltd. Preparation of form 1 ranitidine hydrochloride
WO1993023360A1 (fr) * 1992-05-12 1993-11-25 Zeria Pharmaceutical Co., Ltd. Nouveaux sels d'ammonium quaternaires et utilisation de ces sels comme medicament
CN1063442C (zh) * 1995-05-18 2001-03-21 泽里新药工业株式会社 氨基噻唑衍生物、含有它们的药物组合物及其用途
CN1072652C (zh) * 1996-10-24 2001-10-10 泽里新药工业株式会社 取代的苯甲酰氨基噻唑衍生物以及含有它们的药物
US6152966A (en) * 1998-05-13 2000-11-28 Novo Nordisk A/S Treatment of cork with a phenol oxidizing enzyme
EP1124794A1 (en) 1998-11-05 2001-08-22 Novo Nordisk A/S Substituted 3,3-diamino-2-propenenitriles, their preparation and use
US6362205B2 (en) 1998-11-05 2002-03-26 Novo Nordisk A/S Substituted 3,3-diamino-2-propenenitriles, their preparation and use
WO2005055715A2 (en) * 2003-12-04 2005-06-23 Fmc Corporation Insecticidal n-(heteroarylalkyl) alkanediamine derivatives
CN111303087B (zh) * 2020-04-07 2021-08-10 自然资源部第三海洋研究所 呋喃酮类化合物及其制备方法与应用

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4048058A (en) * 1975-08-13 1977-09-13 Standard Oil Company (Indiana) Methods to be used in reforming processes employing multi-metallic catalysts
GB1565966A (en) * 1976-08-04 1980-04-23 Allen & Hanburys Ltd Aminoalkyl furan derivatives
FI832520L (fi) * 1982-07-12 1984-01-13 Bristol Myers Co Farmaceutiska foerfaranden och sammansaettningar
US4458077A (en) * 1982-11-22 1984-07-03 American Home Products Corporation Heterocyclic anti-ulcer agents
GB2209163B (en) * 1987-08-28 1991-04-24 Toyama Chemical Co Ltd Amine derivative and its salt, process for producing the same, and anti-ulcer agent containing the same

Also Published As

Publication number Publication date
DE69021294T2 (de) 1996-01-25
EP0413343B1 (en) 1995-08-02
ATE125805T1 (de) 1995-08-15
JPH0730064B2 (ja) 1995-04-05
CA2023311A1 (en) 1991-02-18
JPH03163074A (ja) 1991-07-15
ES2075098T3 (es) 1995-10-01
DK0413343T3 (da) 1995-12-11
GR3017870T3 (en) 1996-01-31
EP0413343A3 (en) 1992-04-22
EP0413343A2 (en) 1991-02-20
CA2023311C (en) 1999-11-02
US5075301A (en) 1991-12-24
DE69021294D1 (de) 1995-09-07

Similar Documents

Publication Publication Date Title
LU90829I2 (fr) Tepoxalin-zubrin et ses d-riv-s pharmaceutiquement acceptables
LU90219I2 (fr) Tolcapone et ses dérivés pharmaceutiquement acceptables (TASMAR)
LU90951I2 (fr) Eurifel rcp felv et ses dérivés pharmaceutiquement acceptables
LU90769I2 (fr) Capecitabine et ses d-riv-es pharmaceutiquement acceptables (xeloda)
AU4467589A (en) Treatment of skin diseases with artemisinin and derivatives
PT82591A (en) Ascorbic acid derivatives production and use thereof
EP0421946A3 (en) 3-indolepyruvic acid derivatives their method of production and therapeutic use
EP0292437A3 (en) Piperidylaminotriazine derivatives and their use as stabilizers
LU88790I2 (fr) Moxidectin et ses dérivés pharmaceutiquement acceptables
HK1006459A1 (en) Furan derivatives
EG18822A (en) Production and use of prophyrins
HU9203157D0 (en) 24-oxa derivatives pertaining to series of vitamine d
CS189389A2 (en) Method of cephalosporin's new derivatives production
GR3004487T3 (ja)
JPS6438082A (en) Manufacture of ascorbic acid derivative
JPS5419959A (en) Novel daunobicine derivative * production thereof and use of same as drug
IL82244A (en) Five-membered heterocyclic derivatives of n'-substituted-n,n'-diacylhydrazines and their use as insecticides
CA1271748C (en) BENZAZEPINE DERIVATIVES
GB2205100B (en) Derivatives of tetrahydrofuran and tetrahydrothiophen
AU3747489A (en) Use of special amines to prevent nitrosamine formation
GR3015704T3 (en) Glycerin derivative and its pharmacological use.
PH24297A (en) Thiophene derivatives and their use as pharmaceuticals
EG19066A (en) New derivatives of cysteine
KR900700484A (ko) 1,4:3,6-디안히드로 헥시톨 잘산염의 아미노프로판올 유도체,그의 제법 및 약제로서의 그의 용도
EP0210883A3 (en) Derivatives of penem

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)